AI Terminal

MODULE: AI_ANALYST
Interactive Q&A, Risk Assessment, Summarization
MODULE: DATA_EXTRACT
Excel Export, XBRL Parsing, Table Digitization
MODULE: PEER_COMP
Sector Benchmarking, Sentiment Analysis
SYSTEM ACCESS LOCKED
Authenticate / Register Log In

Aker BioMarine

Report Publication Announcement Mar 28, 2022

3527_10-k_2022-03-28_44ebb7e3-9f66-4d93-a9e2-3e494439d671.html

Report Publication Announcement

Open in Viewer

Opens in native device viewer

Aker BioMarine ASA - Annual Report 2021

Aker BioMarine ASA - Annual Report 2021

28 March 2022: Aker BioMarine ASA today publishes its Annual Report for 2021, which includes the annual accounts, the auditor's report for 2021 and a report on ESG (Environmental, Social and Governance).

The report is attached and is also available at www.akerbiomarine.com.

For further information, please contact

Carl Christian Bachke, Investor Relations

Mobile: +47 909 808 48

Email: [email protected]

This information is subject to the disclosure requirements pursuant to Section 5-12 the Norwegian Securities Trading Act.

About Aker BioMarine

Aker BioMarine is a leading biotech innovator and Antarctic krill-harvesting company developing krill-derived products for pharma, consumer health and wellness as well as animal nutrition. The company has a strong position in its industry and is the world's leading supplier of krill, the natural, powerful and health promoting source of nutrients from the pristine waters of Antarctica. Aker BioMarine is listed on Oslo Stock Exchange (AKBM). More information is available at www.akerbiomarine.com.

Talk to a Data Expert

Have a question? We'll get back to you promptly.